Why Safety Controversies Have Spread to the Consumer Market

As products targeting everyday health concerns such as better sleep or weight management spread rapidly, the risks of supplements and injections used outside medical supervision have also increased. In particular, products promoted through overseas direct purchases and social media advertising, such as gummies containing ashwagandha root extract, and obesity treatments used outside prescription controls have shown that they can lead to serious adverse reactions such as acute pancreatitis.

This trend can be seen as the result of a combination of the perception that natural products or health functional foods are relatively mild and consumer psychology that seeks quick effects. The problem is that risk can vary greatly not so much by whether the product itself is effective, but by differences in duration of use, dosage, concomitant medications, and distribution channels. As a result, the importance of verification and consultation before use has now grown beyond that of freedom of choice alone.

Why Quality Standards and Manufacturing Controls Are Being Accelerated

As the standardization of raw materials and testing information has failed to keep pace with market expansion, the management system is shifting from post-distribution response to stronger prior verification. In the proposed enactment and revision of the Korean Pharmacopoeia, which covers food and drug standards, testing methods for essential medicines and herbal materials were revised, while the upgrading of the Korean Medicine Laboratory Information Management System (KLIMS) can be read as an attempt to standardize scattered research data and create a common language for judging quality.

It is in the same context that companies and professional groups have publicly stepped forward to defend the legality of raw materials or the scope of compounding. The controversy over agarwood extract essence and the dispute within Korean medicine circles over the interpretation of advance compounding are not merely verbal arguments, but show that a broader social reorganization is underway over what standards should determine legality, reliability, and responsibility even in the fields of natural products and traditional medicine.

Corporate Strategy Is Also Shifting From Marketing to Evidence and Production

Companies, too, are moving the axis of competition away from sales driven by trendy ingredients and toward raw material development, integrated production, and the securing of international certifications. Huons N has focused on production infrastructure including FSSC 22000 and on securing functional raw materials, while Daewon Pharmaceutical sought to improve supply stability and quality control by completing an in-house production system for natural product medicines through an investment of about 5 billion won.

This change stems from the judgment that even natural product-based goods must ultimately secure clinical evidence, insurance coverage, and manufacturing credibility in order to build a sustainable market. Cases such as Jitech tablets being included in National Health Insurance reimbursement starting October 1, and Univera’s move to use AI to improve the efficiency of natural product research, show that the natural products industry is shifting from a stage centered on experience and image to one centered on data and institutions.

The Meaning of Domestic Raw Material Localization and Region-Based Expansion

As demands for safety and quality rise, the importance of a stable raw material supply base is also increasing. The development of a new variety of Trichosanthes kirilowii and Jeju’s 8.8 billion won in regionally autonomous R&D projects can be seen not simply as local initiatives, but as industrial strategies aimed at reducing import dependence and linking cultivation, materialization, and commercialization of natural products within the region.

These moves suggest that the future competitiveness of the natural products and health supplement industries is likely to be determined less by advertising power than by raw material traceability, data accumulation, and manufacturing reproducibility. Consumers may face stricter verification procedures and companies may bear greater investment burdens, but only by going through that process can the natural products market move beyond recurring safety controversies and earn institutional trust.